Sign up today to learn more about Humacyte stock

EquityZen is a marketplace for shares of proven pre IPO tech companies

Humacyte Stock

Regenerative Medical Technology Company

Founded

2004

Notable Investors

California Institute for Regenerative Medicine

Headquarters

Morrisville NC, US

Total Funding

$436M

About Humacyte Stock

Humacyte, Inc. develops products for vascular disease and replacement of anatomical conduits. It offers human tissue-based products called human acellular vessels (HAV) for regenerative medicine and vascular surgery applications. The company was incorporated in 2004 and is headquartered in Morrisville, North Carolina.

Investors

Bangkok bank

Humacyte

California Institute for Regenerative Medicine

Humacyte

Pacific Eagle Asset Management

Humacyte

Funding History

January 2015$74.1M
October 2015$136M
March 2018$75.0M
June 2018$150M

Management

Chief Executive Officer

Jeffrey Lawson

Chief Financial Officer

Douglas Blankenship

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Humacyte or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo